Search results
Results From The WOW.Com Content Network
In 1925 Macdonald was appointed research assistant at the Sir Alfred Jones Research Laboratory in Freetown, Sierra Leone, where during the next four years he carried out studies on the effects of malaria in African children. In 1932 he took the post of medical officer for the Mariani Medical Association in Assam. He held this appointment until ...
While a series of research publications came out of the Stateville Penitentiary experiments, the results had a minimal long-term impact on malaria treatment methods. The main legacy of the study is instead the ethical contention raised by prisoner experimentation , manifesting in the trials of Nazi Germany for its experiments on human subjects.
Plasmodium cynomolgi is the second-most studied malaria parasite of non-human primates after Plasmodium knowlesi, primarily due to its similarity to the human parasite P. vivax. [10] In particular, P. cynomolgi is used as a model for hypnozoite biology as it (along with P. vivax ) is one of the few Plasmodium species known to have this ...
He has published more than 280 papers on malaria, with a current h-index of 97. His work has been cited over 34,000 times. His work has been funded by the NIH, the Bill & Melinda Gates Foundation, the Department of Defense, the Burroughs Wellcome Fund and the Medicines for Malaria Venture. [14] [2] [8] [7] [15]
Sir Ronald Ross KCB KCMG FRS FRCS [1] [2] (13 May 1857 – 16 September 1932) was a British medical doctor who received the Nobel Prize for Physiology or Medicine in 1902 for his work on the transmission of malaria, becoming the first British Nobel laureate, and the first born outside Europe.
Download as PDF; Printable version; In other projects Wikidata item; ... Malaria Research and Treatment; Mathematical Problems in Engineering; Mediators of Inflammation;
The Malaria Eradication Research Agenda (malERA) initiative was a consultative process to identify which areas of research and development (R&D) must be addressed for worldwide eradication of malaria. [331] [332]
The logo of the Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness (human African trypanosomiasis, HAT), Chagas disease, [1] malaria, filarial ...